Literature DB >> 33946699

Hydrocephalus Induced by Intraventricular Peroxiredoxin-2: The Role of Macrophages in the Choroid Plexus.

Ting Chen1,2, Xiaoxiao Tan1,2, Fan Xia1, Ya Hua1, Richard F Keep1, Guohua Xi1.   

Abstract

The choroid plexus (CP) is the primary source of cerebrospinal fluid in the central nervous system. Recent evidence indicates that inflammatory pathways at the CP may be involved in hydrocephalus development. Peroxiredoxin 2 (Prx2) is a major component of red blood cells. Extracellular Prx2 is proinflammatory, and its release after red blood cell lysis may contribute to hydrocephalus after intraventricular hemorrhage. This study aimed to identify alterations in CP macrophages and dendritic cells following intracerebroventricular Prx2 injection and investigate the relationship between macrophages/dendritic cells and hydrocephalus. There were two parts to this study. In the first part, adult male Sprague-Dawley rats received an intracerebroventricular injection of Prx2 or saline. In the second part, Prx2 was co-injected with clodronate liposomes or control liposomes. All animals were euthanized at 24 h after magnetic resonance imaging. Immunohistochemistry was used to evaluate macrophages in CP, magnetic resonance imaging to quantify hydrocephalus, and histology to assess ventricular wall damage. The intracerebroventricular injection of Prx2 not only increased the OX-6 positive cells, but it also altered their location in the CP and immunophenotype. Co-injecting clodronate liposomes with Prx2 decreased the number of macrophages and simultaneously attenuated Prx2-induced hydrocephalus and ventricular wall damage. These results suggest that CP macrophages play an essential role in CP inflammation-induced hydrocephalus. These macrophages may be a potential therapeutic target in post-hemorrhagic hydrocephalus.

Entities:  

Keywords:  OX-6; Peroxiredoxin 2; choroid plexus; dendritic cells; hydrocephalus; inflammation; macrophages

Year:  2021        PMID: 33946699     DOI: 10.3390/biom11050654

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  27 in total

1.  Differential expression of peroxiredoxin subtypes in human brain cell types.

Authors:  T A Sarafian; M A Verity; H V Vinters; C C Shih; L Shi; X D Ji; L Dong; H Shau
Journal:  J Neurosci Res       Date:  1999-04-15       Impact factor: 4.164

Review 2.  Macrophage activation and polarization.

Authors:  Fernando Oneissi Martinez; Antonio Sica; Alberto Mantovani; Massimo Locati
Journal:  Front Biosci       Date:  2008-01-01

Review 3.  Dendritic cell migration in health and disease.

Authors:  Tim Worbs; Swantje I Hammerschmidt; Reinhold Förster
Journal:  Nat Rev Immunol       Date:  2016-11-28       Impact factor: 53.106

4.  Activated rat T cells synthesize and express functional major histocompatibility class II antigens.

Authors:  C P Broeren; M H Wauben; M A Lucassen; M Van Meurs; P J Van Kooten; C J Boog; E Claassen; W Van Eden
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

5.  Enhancement of Hematoma Clearance With CD47 Blocking Antibody in Experimental Intracerebral Hemorrhage.

Authors:  Chaohui Jing; Liheng Bian; Ming Wang; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Stroke       Date:  2019-05-14       Impact factor: 7.914

6.  Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal.

Authors:  Sonia Salzano; Paola Checconi; Eva-Maria Hanschmann; Christopher Horst Lillig; Lucas D Bowler; Philippe Chan; David Vaudry; Manuela Mengozzi; Lucia Coppo; Sandra Sacre; Kondala R Atkuri; Bita Sahaf; Leonard A Herzenberg; Leonore A Herzenberg; Lisa Mullen; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-05       Impact factor: 11.205

7.  The choroid plexus is a key cerebral invasion route for T cells after stroke.

Authors:  Gemma Llovera; Corinne Benakis; Gaby Enzmann; Ruiyao Cai; Thomas Arzberger; Alireza Ghasemigharagoz; Xiang Mao; Rainer Malik; Ivana Lazarevic; Sabine Liebscher; Ali Ertürk; Lilja Meissner; Denis Vivien; Christof Haffner; Nikolaus Plesnila; Joan Montaner; Britta Engelhardt; Arthur Liesz
Journal:  Acta Neuropathol       Date:  2017-07-31       Impact factor: 17.088

Review 8.  Role of Human Macrophage Polarization in Inflammation during Infectious Diseases.

Authors:  Chiraz Atri; Fatma Z Guerfali; Dhafer Laouini
Journal:  Int J Mol Sci       Date:  2018-06-19       Impact factor: 5.923

9.  Activation of epiplexus macrophages in hydrocephalus caused by subarachnoid hemorrhage and thrombin.

Authors:  Yingfeng Wan; Ya Hua; Hugh J L Garton; Nemanja Novakovic; Richard F Keep; Guohua Xi
Journal:  CNS Neurosci Ther       Date:  2019-08-21       Impact factor: 5.243

10.  Inflammation of the choroid plexus in progressive multiple sclerosis: accumulation of granulocytes and T cells.

Authors:  Sabela Rodríguez-Lorenzo; Julia Konings; Susanne van der Pol; Alwin Kamermans; Sandra Amor; Jack van Horssen; Maarten E Witte; Gijs Kooij; Helga E de Vries
Journal:  Acta Neuropathol Commun       Date:  2020-02-03       Impact factor: 7.801

View more
  4 in total

1.  Advances in brain barriers and brain fluids research in 2021: great progress in a time of adversity.

Authors:  Richard F Keep; Hazel C Jones; Lester R Drewes
Journal:  Fluids Barriers CNS       Date:  2022-06-09

2.  Impact of sex differences on thrombin-induced hydrocephalus and white matter injury: the role of neutrophils.

Authors:  Kang Peng; Sravanthi Koduri; Fan Xia; Feng Gao; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Fluids Barriers CNS       Date:  2021-08-16

Review 3.  Mechanisms of neuroinflammation in hydrocephalus after intraventricular hemorrhage: a review.

Authors:  Katherine G Holste; Fan Xia; Fenghui Ye; Richard F Keep; Guohua Xi
Journal:  Fluids Barriers CNS       Date:  2022-04-01

4.  Delayed Minocycline Treatment Ameliorates Hydrocephalus Development and Choroid Plexus Inflammation in Spontaneously Hypertensive Rats.

Authors:  Xiaodi Hao; Fenghui Ye; Katherine G Holste; Ya Hua; Hugh J L Garton; Richard F Keep; Guohua Xi
Journal:  Int J Mol Sci       Date:  2022-02-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.